CJC. Christian Johansson

C. Christian Johansson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


C. Christian Johansson has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Charlotta All‐Ericsson

    Ophthalmic Pathology and Oncology Service, St Eric's Eye Hospital, Stockholm, Sweden

    1 shared publication
  • Dimitrios Mougiakakos

    Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden

    1 shared publication
  • Eric Trocme

    Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden

    1 shared publication
  • Mario A. Economou

    Ophthalmic Pathology and Oncology Service, St Eric's Eye Hospital, Stockholm, Sweden

    1 shared publication
  • Olle Larsson

    Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden

    1 shared publication
  • Rolf Kiessling

    Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden

    1 shared publication

Latest Publications

  • Open Access

    Expression and prognostic significance of iNOS in uveal melanoma

    by C. Christian Johansson, Dimitrios Mougiakakos, Eric Trocme, Charlotta All‐Ericsson, Mario A. Economou, Olle Larsson, Stefan Seregard, Rolf Kiessling

    Uveal melanoma (UM) is the most common primary intraocular tumor in adults. Disease metastasis occurs in half of the patients and is uniformly fatal despite systemic therapy. Inducible nitric oxide synthase (iNOS) is associated with disease progression in various malignancies including cutaneous melanoma. In this retrospective cohort, we examined the prognostic value of iNOS in UM by performing immunohistochemistry on paraffin‐embedded sections of primary tumors (90 patients) and matched primary and metastatic hepatic tumors (19 patients) with complete histopathological and clinical data. We show that iNOS is expressed in UM (57% of the patients) and high iNOS levels significantly (p = 0.04; hazard ratio (HR) = 2.3) predict disease‐specific survival (DSS) as assessed by Kaplan‐Meier analysis and univariate Cox's proportional hazards regression model. Furthermore, high iNOS expression in the UM primary tissue was significantly associated with metastatic disease and vice versa. Expression of iNOS in hepatic metastases significantly (p = 0.02) predicted a shortened survival as assessed by Kaplan‐Meier analysis. However, iNOS did not appear to be a significant (p = 0.16; HR = 1.9) factor in the multivariate Cox's regression analysis performed together with the clinical parameters tumor diameter, tumor cell type, and tumor location in which only tumor diameter predicted DSS. In conclusion, iNOS predicts DSS in UM and may play a role in disease progression but it is not an independent prognostic factor.